SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review
15 references·3 citing·41 second hop
Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review (2017)Quality of reporting of harms in randomis…Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension (2013)Reporting of harms data in RC…Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review (2013)Adherence to CONSORT Adverse …Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review (2012)Adherence to CONSORT harms-re…An evaluation of the completeness of safety reporting in reports of complementary and alternative medicine trials (2011)An evaluation of the complete…CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials (2010)CONSORT 2010 Statement: Updat…CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: updat…Reporting of Safety Results in Published Reports of Randomized Controlled Trials (2009)Reporting of Safety Results i…The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry (2008)The impact of the CONSORT sta…Reporting in randomized clinical trials improved after adoption of the CONSORT statement (2006)Reporting in randomized clini…Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (2006)Does the CONSORT checklist im…Reporting of Harm in Randomized, Controlled Trials of Nonpharmacologic Treatment for Rheumatic Disease (2005)Reporting of Harm in Randomiz…Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004)Better Reporting of Harms in …The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist (2002)The reporting of methodologic…The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)The Revised CONSORT Statement…Better reporting of randomised controlled trials: the CONSORT statement (1996)Better reporting of randomise…Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review (2024)Quality of reporting and conc…Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review (2023)Quality of reporting of adver…Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) (2019)Recommendations for the Repor…Empirical Evidence of Bias (1995)Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Epidemiology and Reporting Characteristics of Systematic Reviews (2007)Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals (2012)COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures (2021)Reporting results of cancer treatment (1981)The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement (2007)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)The Reporting of Randomized Clinical Trials Using a Surgical Intervention Is in Need of Immediate Improvement (2006)A Systematic Evaluation of the Impact of STRICTA and CONSORT Recommendations on Quality of Reporting for Acupuncture Trials (2008)Scoping review on interventions to improve adherence to reporting guidelines in health research (2019)Improving the quality of reporting of randomized controlled trials. The CONSORT statement (1996)Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial (2000)Positive psychology interventions: a meta-analysis of randomized controlled studies (2013)CONSORT 2025 statement: updated guideline for reporting randomised trials (2025)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials (2013)CONSORT 2010 statement: extension to randomised pilot and feasibility trials (2016)CONSORT 2010 statement: extension to randomised pilot and feasibility trials (2016)Improving the Quality of Reporting of Randomized Controlled Trials (1996)Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy (2014)Reporting guidelines for oncology research: helping to maximise the impact of your research (2018)Reporting of Late Morbidity After Radiation Therapy in Large Prospective Studies: A Descriptive Review of the Current Status (2019)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (2014)Standards for Reporting Qualitative Research (2014)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting (2000)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Attrition in Randomized Controlled Trials for Pediatric Chronic Conditions (2008)A review of reporting of participant recruitment and retention in RCTs in six major journals (2009)Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review (2016)Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms (2017)CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials (2023)
this work references cited by second hop

References

  • 2010CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials13,365 cited
  • 2001The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration3,828 cited
  • 2010CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials3,824 cited
  • 2004Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement1,588 cited
  • 2006Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review873 cited
  • 1996Better reporting of randomised controlled trials: the CONSORT statement610 cited
  • 2009Reporting of Safety Results in Published Reports of Randomized Controlled Trials285 cited
  • 2006Reporting in randomized clinical trials improved after adoption of the CONSORT statement227 cited
  • 2002The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist167 cited
  • 2013Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review125 cited
  • 2013Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension111 cited
  • 2012Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review65 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2008
The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry
62 cited
  • 2011An evaluation of the completeness of safety reporting in reports of complementary and alternative medicine trials50 cited
  • 2005Reporting of Harm in Randomized, Controlled Trials of Nonpharmacologic Treatment for Rheumatic Disease49 cited
  • Cited by

    • 2019Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)20 cited
    • 2024Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review13 cited
    • 2023Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review9 cited